{"id":"W2891826418","doi":"10.1111/bjh.15571","title":"Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Medicine; Refractory (planetary science); Internal medicine; Oncology; Myeloid leukaemia; Vismodegib; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001557296,0.001373443,0.001889691,0.000353814,0.0003313168,0.001128774,0.0006784474,0.001396547,0.00396975],"category_scores_gemma":[0.001109672,0.0003190424,0.001512343,0.0002971097,0.0007418912,0.0008854049,0.0003172852,0.003098803,0.001072728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001005153,"about_ca_system_score_gemma":0.0007724502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005649563,"about_ca_topic_score_gemma":0.001701909,"domain_scores_codex":[0.9996061,0.0001787334,0.00002125697,0.00006980017,0.00004762533,0.00007657099],"domain_scores_gemma":[0.9994606,0.00009467766,0.0001047424,0.00004792789,0.00004299331,0.0002490324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7298749,0.02417714,0.00363908,0.002107495,0.002713152,0.0002850202,0.0002814797,0.003219233,0.04372441,0.0006290753,0.0081103,0.1812387],"study_design_scores_gemma":[0.6357903,0.3292568,0.01561998,0.0002262849,0.001139724,0.0007226188,0.0001043016,0.002447466,0.004807804,0.001160893,0.008655896,0.00006790321],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801803,0.009120835,0.000736665,0.001157728,0.0002096692,0.002262846,0.002221127,0.000228042,0.003882898],"genre_scores_gemma":[0.9800795,0.006178752,0.001862866,0.002064083,0.0001871753,0.00235918,0.003492711,0.00006127661,0.003714543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00396975,"threshold_uncertainty_score":0.01328015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01730731835137789,"score_gpt":0.2859015892973599,"score_spread":0.268594270945982,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}